0 CHECKOUT

Pen Injectors to 2022

  • ID: 3064207
  • January 2015
  • Region: Global
  • Greystone Associates
Devices, Drugs, Combination Product

User-friendly designs and the availability of an increasing number of drugs in pre-filled disposable cartridges and syringes are propelling the growth of injector pens at the expense of other drug delivery methods such as traditional syringes. Advances in synthetic materials and concurrent development partnerships between pen designers and drug developers are important factors in the growth of this segment. With product evaluations, industry data and forecasts, pen injector company profiles, and detailed analysis of design and economic factors, this report has been organized and written to provide pharmaceutical professionals, drug delivery market participants, and healthcare organizations with all of the information necessary to understand the growing importance of pen injectors on drug development and delivery.

Highlights

- Provides detailed analysis of pen injector market segments, market dynamics and market demographics

- Analyzes therapeutic demand drivers and evaluates commercial pen injector products in eleven major therapeutic segments

- Analyzes design factors, material selection issues, technologies and market development issues

- Profiles injectable drug and device participants, their pen injector product development activities, business strategies, and corporate alliances and affiliations

Note: Product cover images may vary from those shown

1. Executive Summary

2. Injectable Drug Sector Market Dynamics
- The Injectable Drug Ecosystem
- Drug Classes, Indications and Demand
- What’s Driving the Growth in Pen Injectors
- Biological Drugs Proliferating
- Growth of Self-Administration
- Shifting Demographics
- Device Design Innovation
- Competitive Landscape
- Risk Factors

3. Pen Injector Design Selection Factors
- Standardized Pen Platforms
- Custom Pen Designs
- Reusable Pens
- Prefilled Pen Cartridges
- Disposable Pens
- Dual Chamber Pens
- Variable vs Fixed Dosing
- Autoinjectors
- Reusable Autoinjectors
- Disposable Autoinjectors

4. Important Pen-Delivered Drug Classes
- Anticholonergics
- Dopamine Receptors
- Hematopoietics
- Human Growth Hormone
- Immune Modulators
- Insulins and Antihyperglycemics
- Parathyroid Hormone
- Reproductive Hormones
- Serotonin Antagonists
- Sympathomimetics

5. Pen Injectors - Therapeutic Sector Assessment
- Anemia
- Inflammatory Autoimmune Diseases
- Diabetes
- Emergency Medicine
- Hepatitis
- Hormone Replacement
- Osteoporosis
- Reproductive Health
- Other Commercial Pen Markets & Products

6. Market Factors
- Regulatory Considerations
- Patient Preferences and Compliance
- Managed Care Initiatives
- Private Labeling

7. Pen Injectors - Company Profiles

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Bayer AG
  • LEO Laboratories Ltd.
  • Grünenthal GmbH
  • Medtronic, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Pall Corporation